Additionally, CSF DNA genotyping was associated with survival outcomes among LUAD patients with central nervous system (CNS) metastasis [13] and Osimertinib response of LM in EGFR-mutated NSCLC [14]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.